Comprehensive Evaluation and Management of Hepatitis B

Introduction to Hepatitis B Evaluation

• The American Association for the Study of Liver Diseases recommends a systematic workup for all HBsAg-positive patients, including confirmation testing, viral replication markers, liver function assessment, and screening for coinfections 1, 2, 3

Immediate Confirmatory Testing

• Repeat HBsAg testing at a different time point is necessary to confirm chronicity, as a single positive test may represent acute infection 4
• Ordering IgM anti-HBc can distinguish acute from chronic infection, with positive IgM indicating acute infection and its absence confirming chronic infection 5, 1, 2

Essential Viral Replication Markers

• HBeAg and anti-HBe testing is mandatory to determine disease phase, with HBeAg-positive indicating high viral replication and anti-HBe-positive suggesting lower replication 1, 2, 3
• Quantitative HBV DNA level is critical for treatment decisions, with levels ≥20,000 IU/mL in HBeAg-positive or ≥2,000 IU/mL in HBeAg-negative patients indicating active chronic hepatitis requiring treatment consideration 1, 2, 3

Comprehensive Liver Disease Assessment

• A complete blood count with platelets is necessary to assess for cytopenias suggesting portal hypertension 1, 2, 3
• Liver function panel, including AST/ALT, alkaline phosphatase, GGT, total bilirubin, albumin, and prothrombin time/INR, is essential to evaluate synthetic function and degree of liver injury 1, 2, 3

Mandatory Coinfection Screening

• HIV testing is required for all HBsAg-positive patients, as coinfection accelerates liver disease progression and alters treatment approach 4, 5, 1, 2, 3
• Anti-HCV antibody testing is necessary to detect hepatitis C coinfection, which significantly worsens prognosis 5, 1, 2, 3

Hepatitis A Immunity Assessment

• IgG anti-HAV testing is essential to assess immunity, particularly in patients younger than 50 years in developed countries where natural immunity rates have declined 1, 2, 3
• Vaccination with 2-dose hepatitis A vaccine series is recommended for all anti-HAV negative patients to prevent superimposed acute hepatitis A 5, 1, 2, 3

Hepatocellular Carcinoma Surveillance

• Baseline abdominal ultrasound should be performed in all HBsAg-positive patients age 20 and older at initial presentation to screen for hepatocellular carcinoma 5, 1, 2, 3
• Serum alpha-fetoprotein (AFP) is part of the HCC screening protocol 1, 2, 3

Critical History and Physical Examination Elements

• A family history of HBV infection, liver disease, and HCC is crucial, as a positive family history of cirrhosis/HCC warrants treatment even without advanced fibrosis 5, 1, 2, 3
• Alcohol consumption history is important, with strong counseling for complete abstinence, as alcohol accelerates progression to cirrhosis 4, 5, 1, 2, 3

Contact Management and Prevention

• Identifying and vaccinating all sexual and household contacts who lack immunity (anti-HBs negative) is necessary to prevent transmission 4, 5, 1, 2, 3
• Counseling on transmission prevention, including safe sex practices and avoiding sharing of personal items, is essential 4, 5, 1, 2, 3

Ongoing Monitoring Schedule

• ALT monitoring every 3-6 months is recommended for all HBsAg-positive patients, even those not on treatment 1, 2, 3
• HBV DNA levels should be monitored periodically to detect changes in viral replication status 1, 2, 3
• HBeAg/anti-HBe status should be rechecked if initially HBeAg-positive to detect seroconversion 1, 2, 3